MADISON, Wis. — Abbott expects to close its acquisition of Exact Sciences on Monday, the healthcare giant said.
Madison-based Exact Sciences is known for its cancer detection technology such as Cologuard. Abbott announced last year that it would buy the company for $23 billion.
“The addition of Exact Sciences enhances Abbott’s growth profile and strengthens our leadership in diagnostics,” Abbott chairman and CEO Robert Ford said in a statement on Friday. ” This transaction brings a powerful new platform in cancer screening and diagnostics into Abbott, advancing our mission to make care more accessible and give people more control over their health.”…